Low-Dose Naltrexone for Managing Pain and Autonomic Symptoms in Patients With Dysautonomia

Zapata N, Georgiadi E, Cantrell C, et al. (June 22, 2025)

Cureus 17(6): e86538. doi:10.7759/cureus.86538

Breakthrough book spotlights the life-changing potential of low dose naltrexone (LDN) for chronic pain and complex conditions

The Phoenix Newspaper | Health and Wellbeing
8th June 2025


With millions suffering silently from chronic pain and complex conditions, The LDN Book 4: Case Studies in Chronic Pain (LDN Research Trust) is offering timely and life-changing insights into one of medicine's best-kept secrets — low dose naltrexone (LDN).

Commentary: Article May 12, 2025
 

Can Low-Dose Naltrexone Fill the Gaps in Palliative Pain Management?

Author(s):Emma Murter, PharmD, MPH, Madison N. Irwin, PharmD, BCPS

https://www.pharmacytimes.com/view/can-low-dose-naltrexone-fill-the-gaps-in-palliative-pain-management-

Low-Dose Naltrexone in Pain Management and Inflammatory Disorders

Nature Research Intelligence

https://www.nature.com/research-intelligence/low-dose-naltrexone-in-pain-management-and-inflammatory-disorders

November 7, 2024
By Lauren Massaro

https://www.drugtopics.com/view/q-a-pharmacists-champion-nonopioid-pain-management-strategies

Melissa Durham, PharmD, MACM, reveals how pharmacists are uniquely positioned to counsel patients on nonopioid pain management.

Pain specialist Dr Chris Kleronomos from Oregon us talks about how he used Ultra low dose naltrexone and LDN in his clinic.Dr.

Digital Journal.com

AgelessRx Reports Promising Results from LDN Quality of Life Study for Healthy Aging

PRESS RELEASE

Dr. Dana of Love Health Direct Primary Care: A beacon of hope for Ehlers-Danlos and other chronic pain syndromes

May 13th, 2024 | By Ryan Genova

Glenside Local - Local News, Events and Buzz in Glenside, Jenkintown, Abington, Roslyn and Wyncote.